USDA Import BSE Restriction Waiver Sought For IVD Products
This article was originally published in The Gray Sheet
Executive Summary
FDA and AdvaMed will meet with USDA during the first week of September to discuss whether BSE import restrictions should apply to in vitro diagnostic (IVD) products that contain ruminant-derived materials